Covid-19 | Subscribe | FAQs

Logo Logo Logo Logo Logo
  • About us
    • Who we are
    • Board
    • Executive Management
    • Expressions of Interest
    • Quality Management System
    • Regulatory Partnerships
    • Special Projects
      • Backlog
    • Vacancies
    • Tenders
  • Operational Units
    • Biologicals
      • Communication to Industry
      • Forms
      • Guidelines
    • Complementary Meds
      • Application portal
      • Communication to Industry
      • Forms
      • Guidelines
      • Templates
    • Clinical Trials
      • Communication To Industry
      • Forms
      • Guidelines
    • Inspectorate and Regulatory Compliance
    • Medical Devices
      • Communication to Industry
      • Forms
      • Guidelines
      • Conformity assessment bodies
      • Licenced Establishments
      • Position Statements
      • Related Documents
      • Test Kits
    • Names and Scheduling
      • Amended Schedules
      • Consolidated Schedules
      • Guidelines
    • Orthodox Medicines
      • Communication to Industry
      • Forms
      • Guidelines
      • Registered Health Products
      • Templates
    • Radiation Control
      • Acts and Regulations
      • Forms
      • Guidelines & Codes of Practice
      • News & Updates
    • Safety Information
      • Covid-19 Adverse Events Report
      • Health Product Vigilance
      • Product Recalls
      • Rapid Alerts
      • Recalls Reporting
      • Report Side Effects
      • Safety Alerts
    • Unregistered Products
      • Category A Medicines
      • Complementary Medicines
      • Medical Devices
      • Veterinary Medicines
    • Veterinary Medicines
      • Guidelines
      • Registered Vet Products
      • Veterinary Portal
  • Databases & Registers
    • Medical Devices Licences Issued
    • OTC Medicines Directory
    • Pharma Licenced Establishments
      • Revoked or Suspended Pharma Licences
    • PI & PIL Repository
    • Registered Health Products
    • Registered Vet Products
  • E-Services
    • Adverse Drug Reaction Reporting
    • AEFI Reporting Dashboard
    • Complementary Medicines Licensing
    • COVI-VIG Reporting System
    • Health Product Application Status Checker
    • Lot Release Search
    • OTC Medicines Directory
    • Product Variations Portal
    • Med Safety App
    • Registered Health Products
    • Section 21 Applications
    • Variations Status Checker
    • Veterinary portal
  • E-Library
    • Corporate & Publications
      • Annual Reports
      • Documents For Comments
      • Fees
      • Newsletters
      • Planning Documents
      • Position Statements
      • Published Papers
    • Forms
    • Guidelines
      • Guidelines Notice Board
    • Policies & Regulations
      • Acts And Regulations
      • Govt Gazettes And Regulations
      • Policies
    • Presentations
    • Templates
  • News
    • News & Updates
    • Press Releases
    • Communication to Industry
    • Documents For Comments
    • Events
    • NDOH Updates
    • Podcasts
    • Public Information Portal
    • Safety Alerts
    • THC and CBD Information
    • Videos
  • Contact Us
    • General Enquiries
    • Key Contacts
    • Media enquiries
    • Our Offices
    • Whistleblower/Non-Compliance Reporting
    • Recalls Reporting
  • About us
    • Who we are
    • Board
    • Executive Management
    • Expressions of Interest
    • Quality Management System
    • Regulatory Partnerships
    • Special Projects
      • Backlog
    • Vacancies
    • Tenders
  • Operational Units
    • Biologicals
      • Communication to Industry
      • Forms
      • Guidelines
    • Complementary Meds
      • Application portal
      • Communication to Industry
      • Forms
      • Guidelines
      • Templates
    • Clinical Trials
      • Communication To Industry
      • Forms
      • Guidelines
    • Inspectorate and Regulatory Compliance
    • Medical Devices
      • Communication to Industry
      • Forms
      • Guidelines
      • Conformity assessment bodies
      • Licenced Establishments
      • Position Statements
      • Related Documents
      • Test Kits
    • Names and Scheduling
      • Amended Schedules
      • Consolidated Schedules
      • Guidelines
    • Orthodox Medicines
      • Communication to Industry
      • Forms
      • Guidelines
      • Registered Health Products
      • Templates
    • Radiation Control
      • Acts and Regulations
      • Forms
      • Guidelines & Codes of Practice
      • News & Updates
    • Safety Information
      • Covid-19 Adverse Events Report
      • Health Product Vigilance
      • Product Recalls
      • Rapid Alerts
      • Recalls Reporting
      • Report Side Effects
      • Safety Alerts
    • Unregistered Products
      • Category A Medicines
      • Complementary Medicines
      • Medical Devices
      • Veterinary Medicines
    • Veterinary Medicines
      • Guidelines
      • Registered Vet Products
      • Veterinary Portal
  • Databases & Registers
    • Medical Devices Licences Issued
    • OTC Medicines Directory
    • Pharma Licenced Establishments
      • Revoked or Suspended Pharma Licences
    • PI & PIL Repository
    • Registered Health Products
    • Registered Vet Products
  • E-Services
    • Adverse Drug Reaction Reporting
    • AEFI Reporting Dashboard
    • Complementary Medicines Licensing
    • COVI-VIG Reporting System
    • Health Product Application Status Checker
    • Lot Release Search
    • OTC Medicines Directory
    • Product Variations Portal
    • Med Safety App
    • Registered Health Products
    • Section 21 Applications
    • Variations Status Checker
    • Veterinary portal
  • E-Library
    • Corporate & Publications
      • Annual Reports
      • Documents For Comments
      • Fees
      • Newsletters
      • Planning Documents
      • Position Statements
      • Published Papers
    • Forms
    • Guidelines
      • Guidelines Notice Board
    • Policies & Regulations
      • Acts And Regulations
      • Govt Gazettes And Regulations
      • Policies
    • Presentations
    • Templates
  • News
    • News & Updates
    • Press Releases
    • Communication to Industry
    • Documents For Comments
    • Events
    • NDOH Updates
    • Podcasts
    • Public Information Portal
    • Safety Alerts
    • THC and CBD Information
    • Videos
  • Contact Us
    • General Enquiries
    • Key Contacts
    • Media enquiries
    • Our Offices
    • Whistleblower/Non-Compliance Reporting
    • Recalls Reporting
Safety of the COVID-19 Vaccine Janssen – response to restrictions imposed in the US- Image sourced from Pixabay/Pexels
torstensimon via Pixabay

23 Jun SAHPRA and the Sinopharm Vaccine

Posted at 18:14h in News & Updates, Press Releases by Ntokozo Msiza
Share

23 June 2021

SAHPRA has received documentation for the Sinopharm vaccine developed by the China National Pharmaceutical Group in China.

SAHPRA will now commence with evaluating the data in assessing the efficacy of the vaccine.

Download PDF

Tags:
China National Pharmaceutical Group, COVID‑19 vaccine, SAHPRA, Sinopharm, vaccine


Facebook Feed
1 month ago

Register for an Africa Continental Good Regulatory Practices Workshop – hosted by @USAID_SAfrica @USAID @ansidotorg @AdvaMedUpdate

For more info 👉 https://www.sahpra.org.za/news-and-updates/register-for-an-africa-continental-good-regulatory-practice-workshop/

Register here: https://us06web.zoom.us/webinar/register/WN_fJMuW5PhSHiPFt5mZlKkrg

#AdvaMED
#SAHPRA
#medicaldevices
#USAID
#GRPs
... See more

View on facebook
1 month ago

New Year means a new opportunity full of success and prosperity. #SAHPRA would like to wish you all a happy and prosperous new year!

#HappyNewYear

View on facebook
CONTACT US

General Enquiries
For general, non-product specific enquiries only.
enquiries@sahpra.org.za

For Emergencies
For emergencies only.
emergency@sahpra.org.za

 

Whistleblower

Quick Menu
  • Home
  • Covid-19 Updates
  • Expressions of Interest
  • NDOH Updates
  • Safety Information
  • Payment Guideline
  • Tenders
  • THC and CBD information
I want to..

Home

Apply for a vacancy

Contact SAHPRA

Know about SAHPRA

See Health Products

Read News & Updates

Newsletter Subscription

    © 2022 SAHPRA. ALL RIGHTS RESERVED

    Follow us